Specialized pro-resolving mediators in diabetes: novel therapeutic strategies.

Brennan, Eoin P; Mohan, Muthukumar; Andrews, Darrell; Bose, Madhura; Kantharidis, Phillip

Brennan, Eoin P; Mohan, Muthukumar; Andrews, Darrell; Bose, Madhura; Kantharidis, Phillip.

Afiliação

Brennan EP; UCD Diabetes Complications Research Centre, UCD Conway Institute of Biomolecular and Biomedical Research, UCD School of Medicine, University College Dublin, Dublin 4, Ireland.
Mohan M; Department of Diabetes, Central Clinical School, Monash University, Clayton, Vic, Australia.
Andrews D; UCD Diabetes Complications Research Centre, UCD Conway Institute of Biomolecular and Biomedical Research, UCD School of Medicine, University College Dublin, Dublin 4, Ireland.
Bose M; Department of Diabetes, Central Clinical School, Monash University, Clayton, Vic, Australia.
Kantharidis P; Department of Diabetes, Central Clinical School, Monash University, Clayton, Vic, Australia.

Clin Sci (Lond) ; 133(21): 2121-2141, 2019 11 15.

Article em En | MEDLINE | ID: mdl-31693730

Assuntos

Diabetes Mellitus/tratamento farmacológico; Angiopatias Diabéticas/tratamento farmacológico; Terapia de Alvo Molecular; Diabetes Mellitus/classificação; Angiopatias Diabéticas/etiologia; Humanos

Palavras-chave

cardiovascular disease; diabetic nephropathy; inflammation; therapeutics; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Angiopatias Diabéticas / Terapia de Alvo Molecular Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google